Trials / Conditions / Non-small Cell Lung Cancer Stage II

Non-small Cell Lung Cancer Stage II

18 registered clinical trials studyying Non-small Cell Lung Cancer Stage II — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer NCT07428044	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial L NCT07323732	Memorial Sloan Kettering Cancer Center	Phase 2
Active Not Recruiting	A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourc NCT06268613	Samsung Bioepis Co., Ltd.	Phase 1
Unknown	Combining ICI With SBRT or HypoFrx-RT for ES NSCLC NCT05451173	Alexander Chi	Phase 1 / Phase 2
Completed	Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients W NCT05807893	Sun Yat-sen University	Phase 2 / Phase 3
Unknown	Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer NCT06341387	European Institute of Oncology	—
Recruiting	Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) NCT04585477	Stanford University	Phase 2
Active Not Recruiting	Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy NCT04716946	Memorial Sloan Kettering Cancer Center	Phase 2
Unknown	Dose-painting Radiation for LA-NSCLC NCT05031533	Sichuan Cancer Hospital and Research Institute	N/A
Completed	The Canada Lymph Node Score Project: A Crossover Trial NCT04342377	St. Joseph's Healthcare Hamilton	Phase 3
Unknown	Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC NCT04586465	Fifth Affiliated Hospital, Sun Yat-Sen University	Phase 2
Active Not Recruiting	Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resecta NCT04699721	Xiangya Hospital of Central South University	Phase 2
Unknown	Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) NCT04040361	Masahiro Tsuboi	Phase 2
Completed	SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects NCT03383302	Royal Marsden NHS Foundation Trust	Phase 1 / Phase 2
Completed	Oncoxin® and Quality of Life in Cancer Patients NCT03550482	Catalysis SL	Phase 4
Recruiting	Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Pa NCT02622581	AIO-Studien-gGmbH	—
Unknown	LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC NCT01795521	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2
Completed	Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC) NCT01991418	Hunan Province Tumor Hospital	—